Showing results (1551-1560 of 1,879) with videos related to
Sort By:
Pageof 188
Immunotherapy|August 4, 2016
A recombinant TGF-β1 vaccine ameliorates diabetic nephropathy in OLETF ratsHaojun Zhang, Hua Wang, Meihua Yan, et al.Immunotherapy|August 4, 2016
Current status of engineered T-cell therapy for synovial sarcomaMatthew Dallos, William D Tap, Sandra P D'AngeloImmunotherapy|August 4, 2016
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapyFrancesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.Immunotherapy|August 4, 2016
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipientsDaniele Lilleri, Giuseppe GernaImmunotherapy|May 8, 2020
Non-coding RNA and immune-checkpoint inhibitors: friends or foes?Dmitrii Shek, Scott A Read, Liia Akhuba, et al.Immunotherapy|May 5, 2020
Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case reportYuki Iijima, Rie Sakakibara, Masahiro Ishizuka, et al.Immunotherapy|June 13, 2015
CAR T-cell therapy: toxicity and the relevance of preclinical modelsMilena Kalaitsidou, Gray Kueberuwa, Antje Schütt, et al.Immunotherapy|April 30, 2020
Endocrine adverse events related with immune checkpoint inhibitors: an update for cliniciansMaria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T TrafalisImmunotherapy|April 16, 2020
Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?Joseph Kattan, Clarisse Kattan, Tarek AssiImmunotherapy|February 18, 2010
Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapyBurles A Johnson, Babak Baban, Andrew L MellorPageof 188